Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

  • Health Policy
    April 1st, 2024

    The Centers for Medicare and Medicaid Services announced guidelines mandating explicit patient consent for medical students to conduct pelvic and other sensitive exams on anesthetized patients for training. This move aims to standardize patient rights and ensure informed consent nationwide, addressing longstanding concerns over invasive procedures [...]

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

04/23/2024 04:45 PM ET

Zevra Therapeutics ZVRA date announcement

Zevra Therapeutics already had three catalyst announcements coming up, but they added another one today. On June 30, 2024, it will announce top-line results for their recent Phase 1 trial for KP1077. Our calculations show [...]

Read More
04/23/2024 04:45 PM ET

YS Biopharma Co. Ltd. YS date announcement

Now that the Phase 2/3 trial of PIKA Recombinant COVID-19 Vaccine is completed, YS Biopharma Co. Ltd. will announce their top-line results on June 30, 2024. Our predictive system gives the drug a 46% chance [...]

Read More
04/23/2024 04:45 PM ET

ABVC BioPharma TNXP date announcement

After specifying an announcement date for TNX-102 SL - (PREVAIL) trial results, Tonix Pharmaceuticals Holding now has three catalyst announcements planned. On June 30, 2024, Tonix Pharmaceuticals Holding will announce top-line results for their recent [...]

Read More
04/23/2024 04:45 PM ET

Abeona Therapeutics PPBT date announcement

Now that the Phase 1/2 trial of NT-219 is completed, Purple Biotech Ltd. will announce their top-line results on June 30, 2024. Our calculations show a 60.9% chance that the drug makes it to the [...]

Read More

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top